Browse > Article
http://dx.doi.org/10.4014/jmb.1603.03015

Proteomic Analysis of Shigella Virulence Effectors Secreted under Different Conditions  

Liu, Xingming (State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Biotechnology)
Lu, Lilan (State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Biotechnology)
Liu, Xinrui (College of Life Sciences, Capital Normal University)
Liu, Xiankai (State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Biotechnology)
Pan, Chao (State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Biotechnology)
Feng, Erling (State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Biotechnology)
Wang, Dongshu (State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Biotechnology)
Niu, Chang (College of Life Sciences, Capital Normal University)
Zhu, Li (State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Biotechnology)
Wang, Hengliang (State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Biotechnology)
Publication Information
Journal of Microbiology and Biotechnology / v.27, no.1, 2017 , pp. 171-178 More about this Journal
Abstract
A series of novel effector molecules secreted by the type three secretion system (T3SS) of Shigella spp. have been reported in recent years. In this study, a proteomic approach was applied to study T3SS effectors systematically. First, proteins secreted by the S. flexneri wild-type strain after Congo Red induction were separated and identified using two-dimensional electrophoresis to display the relative abundance of all kinds of early effectors for the first time. Then, a gene deletion mutant of known virulence repressor (OspD1) and a gene overexpressed mutant of two known virulence activators (MxiE and IpgC) were constructed and analyzed to discover potential late effectors. Furthermore, the supernatant proteins of gene deletion mutants of two known translocators (IpaB and IpaD), which would constantly secrete effectors, were also analyzed. Among all of the secreted proteins identified in our study, IpaH1.4, IpaH_5, and IpaH_7 have not been reported before. These proteomics data of the secreted effectors will be valuable to understand the pathogenesis of S. flexneri.
Keywords
Shigella flexneri; T3SS; early effectors; late effectors; proteomics;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Preston GM. 2007. Metropolitan microbes: type III secretion in multihost symbionts. Cell Host Microbe 2: 291-294.   DOI
2 Coburn B, Sekirov I, Finlay BB. 2007. Type III secretion systems and disease. Clin. Microbiol. Rev. 20: 535-549.   DOI
3 Dean P. 2011. Functional domains and motifs of bacterial type III effector proteins and their roles in infection. FEMS Microbiol. Rev. 35: 1100-1125.   DOI
4 Liu X, Lu L, Liu X, Pan C, Feng E, Wang D, et al. 2015. Comparative proteomics of Shigella flexneri 2a strain 301 using a rabbit ileal loop model reveals key proteins for bacterial adaptation in host niches. Int. J. Infect. Dis. 40: 28-33.   DOI
5 Demers JP, Sgourakis NG, Gupta R, Loquet A, Giller K, Riedel D, et al. 2013. The common structural architecture of Shigella flexneri and Salmonella typhimurium type three secretion needles. PLoS Pathog. 9: e1003245.   DOI
6 Parsot C. 2009. Shigella type III secretion effectors: how, where, when, for what purposes? Curr. Opin. Microbiol. 12: 110-116.   DOI
7 Dohlich K, Zumsteg AB, Goosmann C, Kolbe M. 2014. A substrate-fusion protein is trapped inside the type III secretion system channel in Shigella flexneri. PLoS Pathog. 10: e1003881.   DOI
8 Schiavolin L, Meghraoui A, Cherradi Y, Biskri L, Botteaux A, Allaoui A. 2013. Functional insights into the Shigella type III needle tip IpaD in secretion control and cell contact. Mol. Microbiol. 88: 268-282.   DOI
9 Troisfontaines P, Cornelis GR. 2005. Type III secretion: more systems than you think. Physiology (Bethesda) 20: 326-339.   DOI
10 Kuehl CJ, Dragoi AM, Agaisse H. 2014. The Shigella flexneri type 3 secretion system is required for tyrosine kinasedependent protrusion resolution, and vacuole escape during bacterial dissemination. PLoS One 9: e112738.   DOI
11 Datsenko KA, Wanner BL. 2000. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc. Natl. Acad. Sci. USA 97: 6640-6645.   DOI
12 Zhu L, Liu X, Zheng X, Bu X, Zhao G, Xie C, et al. 2010. Global analysis of a plasmid-cured Shigella flexneri strain: new insights into the interaction between the chromosome and a virulence plasmid. J. Proteome Res. 9: 843-854.   DOI
13 Bahrani FK, Sansonetti PJ, Parsot C. 1997. Secretion of Ipa proteins by Shigella flexneri: inducer molecules and kinetics of activation. Infect. Immun. 65: 4005-4010.
14 Brotcke Zumsteg A, Goosmann C, Brinkmann V, Morona R, Zychlinsky A. 2014. IcsA is a Shigella flexneri adhesin regulated by the type III secretion system and required for pathogenesis. Cell Host Microbe 15: 435-445.   DOI
15 Barta ML, Guragain M, Adam P, Dickenson NE, Patil M, Geisbrecht BV, et al. 2012. Identification of the bile salt binding site on IpaD from Shigella flexneri and the influence of ligand binding on IpaD structure. Proteins 80: 935-945.   DOI
16 De Geyter C, Wattiez R, Sansonetti P, Falmagne P, Ruysschaert JM, Parsot C, Cabiaux V. 2000. Characterization of the interaction of IpaB and IpaD, proteins required for entry of Shigella flexneri into epithelial cells, with a lipid membrane. Eur. J. Biochem. 267: 5769-5776.   DOI
17 Le Gall T, Mavris M, Martino MC, Bernardini ML, Denamur E, Parsot C. 2005. Analysis of virulence plasmid gene expression defines three classes of effectors in the type III secretion system of Shigella flexneri. Microbiology 151: 951-962.   DOI
18 Kane CD, Schuch R, Day WA Jr, Maurelli AT. 2002. MxiE regulates intracellular expression of factors secreted by the Shigella flexneri 2a type III secretion system. J. Bacteriol. 184: 4409-4419.   DOI
19 Parsot C, Ageron E, Penno C, Mavris M, Jamoussi K, d'Hauteville H, et al. 2005. A secreted anti-activator, OspD1, and its chaperone, Spa15, are involved in the control of transcription by the type III secretion apparatus activity in Shigella flexneri. Mol. Microbiol. 56: 1627-1635.   DOI
20 Bourdet-Sicard R, Rudiger M, Jockusch BM, Gounon P, Sansonetti PJ, Nhieu GT. 1999. Binding of the Shigella protein IpaA to vinculin induces F-actin depolymerization. EMBO J. 18: 5853-5862.   DOI
21 Picking WL, Coye L, Osiecki JC, Barnoski Serfis A, Schaper E, Picking WD. 2001. Identification of functional regions within invasion plasmid antigen C (IpaC) of Shigella flexneri. Mol. Microbiol. 39: 100-111.   DOI
22 Niebuhr K, Giuriato S, Pedron T, Philpott DJ, Gaits F, Sable J, et al. 2002. Conversion of PtdIns(4,5)P(2) into PtdIns(5)P by the S. flexneri effector IpgD reorganizes host cell morphology. EMBO J. 21: 5069-5078.   DOI
23 Yoshida S, Katayama E, Kuwae A, Mimuro H, Suzuki T, Sasakawa C. 2002. Shigella deliver an effector protein to trigger host microtubule destabilization, which promotes Rac1 activity and efficient bacterial internalization. EMBO J. 21: 2923-2935.   DOI
24 Sanada T, Kim M, Mimuro H, Suzuki M, Ogawa M, Oyama A, et al. 2012. The Shigella flexneri effector OspI deamidates UBC13 to dampen the inflammatory response. Nature 483: 623-626.   DOI
25 Pieper R, Zhang Q, Parmar PP, Huang ST, Clark DJ, Alami H, et al. 2009. The Shigella dysenteriae serotype 1 proteome, profiled in the host intestinal environment, reveals major metabolic modifications and increased expression of invasive proteins. Proteomics 9: 5029-5045.   DOI
26 Marchler-Bauer A, Derbyshire MK, Gonzales NR, Lu S, Chitsaz F, Geer LY, et al. 2015. CDD: NCBI's conserved domain database. Nucleic Acids Res. 43: D222-D226.   DOI